patient stratification

The Dutch multinational is now on track to introduce a kitted version of the assay, which can be run on standard quantitative PCR equipment, by the end of the year.

By pulling in data from Higi health kiosks in retail pharmacies, Interpreta builds continuously updated care from genomics, clinical data, and patient lifestyles.

The British molecular diagnostics company plans to make its array-based test for early-stage Alzheimer's disease available in the US by year end.

The new algorithm, called TOPSPIN, complements the company's MMprofiler test. It is considering making TOPSPIN-generated data available to its MMprofiler patients.

The model incorporates clinical, serological, and gene expression factors, and could be used to tailor treatment choices.

The Cambridge, Massachusetts-based precision medicine firm hopes to translate molecular information into therapies for chronic kidney diseases.

The model could shift which patients receive gene expression profiling assays but might not change the number of tests ordered.

The partners will also work together on a linked clinical genomic data set to guide future treatment decisions.

The Sanger Institute spin-off will use its sequencing and bioinformatics services to link genomic and clinical outcomes data for patient stratification.

NEW YORK (GenomeWeb News) – An investigator at the Cedars-Sinai Oschin Comprehensive Cancer Institute has landed a $300,000 in funding from the Avon Foundation for Women to study blood-based biomarkers that could be used to treat and stratify breast cancer patients.

Pages

A new report highlights the potential threats posed by advances in synthetic biology, NPR reports.

A Bloomberg reporter tried to get her genetic data deleted, but found it's not so simple to do.

Johns Hopkins University's Steven Salzberg and his colleagues have come up with a new estimate for the number of human genes, Nature News reports.

In Genome Research this week: study of intra-tumor heterogeneity, workflow resources for EPIGEN-Brazil, and more.